Taligantinib
Product Specifications
CAS Number
2243235-80-3
Target
VEGFR|||c-Met/HGFR
Related Pathways
Angiogenesis|||Tyrosine Kinase/Adaptors
Bioactivity
Taligantinib (Compound Example 70) is an orally active and selective dual inhibitor targeting vascular endothelial growth factor receptor 2 (VEGFR-2) and hepatocyte growth factor receptor (c-Met) . It effectively suppresses tumor angiogenesis and cell proliferation, and holds potential for the study of solid tumors such as non-small cell lung cancer and hepatocellular carcinoma.
Smiles
O=C(NC1=CC=C(F)C=C1)C2(C(=O)NC3=CC=C(OC4=CC=NC5=CC(OCCCN6CCOCC6)=C7OCCOC7=C54)C(F)=C3)CC2
Molecular Formula
C35H34F2N4O7
Molecular Weight
660.66
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/390881246274175064/T211516
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15334209 1 Vial
Lentiviral human C9orf129 shRNA (UAS) - Lentiviral human C9orf129 shRNA (UAS) (100)
Ask
View Details 
